COEP Insider Trading
Coeptis Therapeutics, Inc. (COEP) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $57.6M, listed on NASDAQ, employing roughly 5 people, carrying a beta of -0.43 to the broader market. Coeptis Therapeutics, Inc. Led by David Mehalick, public since 2020-12-17.
In the last 12 months, Coeptis Therapeutics, Inc. insiders made 0 buy transactions and 0 sale transactions.
| Date | Name | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 4, 2026 | BSG Series CM, LLC | 0 | $0.00 | $0 | |
| Feb 13, 2026 | Cogley Brian | A-Award | 12,500 | $0.00 | $0 |
| Feb 13, 2026 | Cogley Brian | M-Exempt | 10,000 | $10.56 | $105.6K |
| Feb 13, 2026 | Deschamps Philippe | M-Exempt | 5,700 | $10.56 | $60.2K |
| Feb 13, 2026 | Deschamps Philippe | A-Award | 3,250 | $0.00 | $0 |
| Feb 13, 2026 | Calise Chris | A-Award | 3,250 | $0.00 | $0 |
| Feb 13, 2026 | Calise Chris | M-Exempt | 5,700 | $10.56 | $60.2K |
| Feb 13, 2026 | Mehalick David | M-Exempt | 148,875 | $7.05 | $1.0M |
| Feb 13, 2026 | Mehalick David | A-Award | 51,250 | $0.00 | $0 |
| Feb 13, 2026 | Cochran Christopher P. | M-Exempt | 5,700 | $10.56 | $60.2K |
How to Read COEP Insider Activity
Net insider activity is balanced over the trailing twelve months: 0 buys against 0 sales. Balanced activity typically reflects routine compensation-related vesting and tax-driven liquidity rather than directional information signals. The transaction table above includes the filer's reporting name, transaction type, share count, per-share price, and total dollar value where computable. For options traders, insider activity is one input to event-driven sizing alongside earnings calendar, analyst-rating cluster moves, and the implied-vol surface. Form 4 filings (the dominant Section 16 reporting form) must be submitted within two business days of the transaction; clusters of buys across multiple insiders within a short window are the strongest informational pattern. SEC EDGAR carries the underlying source filings for verification and additional historical depth.
Learn how insider trading is reported and how to read the data →